Your Source for Venture Capital and Private Equity Financings

Remedy Robotics Finalizes $62M Series B Funding

2026-11-16
SAN FRANCISCO, CA, Remedy Robotics, a leading healthcare and physical AI company developing robotic systems for cardiovascular care and endovascular intervention, announced it has raised $62 million in Series B funding.
Remedy Robotics, a leading healthcare and physical AI company developing robotic systems for cardiovascular care and endovascular intervention, today announced it has raised $62 million in Series B funding to accelerate its mission of delivering flawless, immediate robotic care to all patients, regardless of location.

The funding will support several major milestones, including a planned pivotal clinical trial in partnership with the University of California and advancement toward FDA approval for neurovascular intervention. Remedy will also deploy prototype N1 Systems across its network of clinical partners.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors